Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. reports news about its U.S. cannabis operations, financial results, dispensary expansion, regulatory developments, and capital actions. The company is a vertically integrated multi-state cannabis operator with established hubs in the Northeast, Southeast, and Southwest, anchored by markets including Arizona, Florida, Ohio, and Pennsylvania. Its updates frequently cover retail sales, margins, cash flow, senior secured note financing, and medical cannabis store openings.
Company announcements also address medical marijuana regulation, including Schedule III rescheduling and DEA registration activity for state-licensed medical operations. Product-related news highlights Trulieve's in-house and partner cannabis brands offered through its dispensary network.
Trulieve (OTCQX: TCNNF) plans a corporate domestication from British Columbia, Canada, to Delaware via a shareholder-approved plan of arrangement. The change is intended to align the corporate structure with U.S. operations and leverage Delaware’s corporate environment, without materially changing current business or operations.
A special shareholder meeting is set for August 5, 2026, with a record date of June 8, 2026. Completion depends on court, shareholder, registrar, and other customary approvals, and the board retains discretion to abandon the transaction.
Trulieve (OTCQX: TCNNF) reported Q1 2026 revenue of $287 million with a 59% gross margin, GAAP net income attributable to common shareholders of $2 million, and adjusted EBITDA of $100 million (35% of revenue). The company generated $56 million cash from operations and ended the quarter with $353 million in cash. Management closed a $60 million private placement of senior secured notes due 2030 and filed DEA registration applications for 206 retail locations following medical marijuana rescheduling to Schedule III.
Trulieve (OTCQX: TCNNF) will open a new medical cannabis dispensary in Belleview, Florida, with a grand opening celebration on May 8, 2026. The store at 5428 SE Abshier Boulevard offers walk-in and express pickup, home delivery statewide, and carries Trulieve in-house and partner brands.
Store hours: 9:00 a.m.–8:45 p.m. Monday–Saturday and 10:00 a.m.–8:00 p.m. Sundays. Veterans receive 20% off; first-time guests qualify for a 60% new-customer discount. More information is available at Trulieve.com and social channels.
Trulieve (OTCQX: TCNNF) filed applications with the U.S. Drug Enforcement Administration to register certain state‑licensed medical marijuana operations under the expedited pathway opened by rescheduling medical marijuana to Schedule III.
For applications submitted within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana is deemed approved unless the DEA notifies otherwise. Trulieve says it operates over 200 dispensaries serving only medical patients.
Trulieve (OTCQX: TCNNF) applauded the April 23, 2026 federal rescheduling of medical marijuana to Schedule III under the Controlled Substances Act. The final order permits FDA‑approved and state licensed medical marijuana products to be reclassified, opens a DEA registration pathway for state operators, and notes Section 280E tax relief for Schedule III sales. The Department announced continued rulemaking with an expedited process and a planned hearing this summer.
Trulieve Cannabis Corp (OTCQX: TCNNF) will hold a conference call on May 7, 2026 at 8:30 AM ET to discuss first quarter 2026 financial and operating results. CEO Kim Rivers and CFO Jan Reese will participate. Dial-in and webcast access are provided for investors and analysts.
Live audio webcast and archived replay will be available at the company's investor events page.
Trulieve (OTCQX: TCNNF) will open a new medical cannabis dispensary, Trulieve Ox Bottom, in Tallahassee on April 20, 2026. The location at 5138 Thomasville Road offers walk-in and express pickup, weekend hours, and a grand opening with specials, discounts, and partner giveaways.
The store will stock Trulieve in-house brands and partner brands, and Trulieve Florida services include home delivery, online ordering, and a 20% veterans discount plus a 60% new-customer discount.
Trulieve (OTCQX: TCNNF) will open a new medical cannabis dispensary in Boca Raton, Florida, with a grand opening celebration on April 24, 2026.
The Glades Road store at 9293 Glades Road will offer walk-in and express pickup, home delivery statewide, extended hours, in-house brands, partner brands, veteran and first-time customer discounts.
Trulieve (OTCQX: TCNNF) opened a new medical cannabis dispensary in Lutz, Florida on April 11, 2026, with a grand opening celebration set for April 24, 2026.
The store at 24408 SR-54 offers walk-in and express pickup, extended hours, in-house and partner brands, home delivery, online ordering, a 20% veterans discount, and a 60% first-time guest discount in Florida.
Trulieve (OTCQX: TCNNF) announced that CEO Kim Rivers established an automatic securities disposition plan effective March 17, 2026. Sales may begin June 17, 2026 and continue until 2.5 million subordinate voting shares are sold, subject to daily volume limits, independent broker execution, and applicable U.S. and Canadian rules.
The ASDP is authorized by the compensation committee, restricts executive discretion, and will be reported under securities laws with filings accessible on SEDI and SEC systems.